PIL - Ritonavir 100 mg Film-coated Tablets: Change history
View Patient Information Leaflet (PIL - Ritonavir 100 mg Film-coated Tablets)
Last updated on this site: 09 Apr 2025
Update SmPC sections 4.3, 4.5 and leaflet sections 2 in line with the reference product (Norvir 100 mg film-coated tablets; EU procedurenumber: EMEA/H/C/000127/IB/0171/G; MAH: AbbVie Deutschland GmbH & Co. KG, Germany).
Last updated on this site: 09 Apr 2025
Update SmPC sections 4.3, 4.5 and leaflet sections 2 in line with the reference product (Norvir 100 mg film-coated tablets; EU procedurenumber: EMEA/H/C/000127/IB/0171/G; MAH: AbbVie Deutschland GmbH & Co. KG, Germany).
-
Changes: (Updated: 09 Apr 2025)
Update SmPC sections 4.3, 4.5 and leaflet sections 2 in line with the reference product (Norvir 100 mg film-coated tablets; EU procedurenumber: EMEA/H/C/000127/IB/0171/G; MAH: AbbVie Deutschland GmbH & Co. KG, Germany).
-
Changes: (Updated: 28 Apr 2023)
Description of update: Type IB: C.I.2.a: To update SmPC and PIL in-line with the product Information of reference product (Norvir 100 mg film-coated tablets, EU procedure number: EU/1/96/016 MAH: AbbVie Deutschland GmbH & Co. KG , Germany) for Ritonavir Accord 100 mg film-coated tablets.
PIL sections updated: 2, 6.
-
Changes: (Updated: 21 Sep 2022)
Initial upload